Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
FTC's fight against PBMs is paused
3 months ago
Law
Eli Lilly adds obesity startup knownwell to its direct-to-consumer service
3 months ago
Startups
Health Tech
Q&A: John Crowley warns biotech is 'dangerously close' to breaking, as tariff threat, markets batter industry
3 months ago
People
FDA+
Judge orders HHS, other agencies to 'undo' probationary worker firings
3 months ago
FDA+
‘It’ll be a challenge’: BIO chief Crowley addresses seismic FDA overhaul
3 months ago
People
FDA+
Eli Lilly sues large compounding pharmacies Empower, Strive over tirzepatide products
3 months ago
Health Tech
RFK Jr. has long criticized drug ads. He just slashed the FDA office that regulates them
3 months ago
FDA+
Marketing
European drug regulator seeks to ‘streamline’ biosimilar approval process
3 months ago
FDA+
Sanofi continues its bet on R&D by poaching GSK’s head of development
3 months ago
People
Updated: J&J’s third talc bankruptcy bid is stopped by Texas federal judge
3 months ago
Law
Federal judge nixes FDA's lab-developed test rule, says it exceeded agency's authority
3 months ago
Law
DC court sides with HHS in Vertex's fertility program fight
3 months ago
Cell/Gene Tx
Law
Merck’s PAH drug cuts risk of serious events by 76% in trial stopped for efficacy
3 months ago
R&D
Lykos’ interim CEO is set to step down
3 months ago
R&D
Judge tosses Amgen's challenge to Colorado drug review board, says suit is 'too speculative'
3 months ago
Law
J&J beats Viatris in patent fight over its antipsychotic drug, staving off competition
3 months ago
Law
CHMP recommends seven label expansions and one new approval, rejects Lilly Alzheimer's drug
3 months ago
FDA+
Milestone's shares dive after FDA again rejects drug for abnormal heart rhythm
3 months ago
Manufacturing
European regulator rejects Lilly's Alzheimer’s drug over potentially fatal side effects
3 months ago
FDA+
Novo inks second obesity deal of the week, with Lexicon oral drug partnership worth up to $1B
3 months ago
Deals
Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025
3 months ago
Startups
With tariffs on the way, generic drugmaking woes could hinder Trump’s reshoring plan
3 months ago
Manufacturing
Kennedy announces 10,000 job cuts at HHS, with major reductions expected at FDA, NIH and CDC
3 months ago
FDA+
Exelixis’ primary cancer drug wins FDA approval for neuroendocrine tumors
3 months ago
R&D
First page
Previous page
12
13
14
15
16
17
18
Next page
Last page